Enhertu injection price in India

1. Enhertu (Fam-trastuzumab deruxtecan-nxki) an Anti – Cancer Drug What is Enhertu ? Enhertu (Fam-trastuzumab deruxtecan-nxki) is used in chemotherapy as a chemo drug and also for Anti – Cancer targeted therapy as an anti cancer drug . How Enhertu helps in fighting Cancer ? Trastuzumab the antibody part targets and gets attached to the Her2 receptor of the cancer cells . Once the Trastuzumab is attached the chemotherapy part (deruxtecan) gets released in the cancer cells and destroys the cancer cells and other surrounding cancer cells . What are the ingredients in Enhertu ? fam-trastuzumab deruxtecan-nxki is the active ingredient in Enhertu and inactive ingredient includes L-histidine, L-histidine hydrochloride monohydrate, polysorbate 80, and sucrose. Can you Explain theTrastuzumab and Deruxtecan section of Enhertu in a better way ? Yes , Enhertu has been made in combination of 2 different cancer drugs that are Trastuzumab section which is a targeted therapy and designed for find and target the Her2 receptor on cancer cells and Deruxtecan section which destroys the cancer cells after it has been targeted . So it is made by two drugs by joining two different ADC ( Antibody -drug conjugate ) . Is enhertu for breast cancer FDA Approves First Targeted Therapy for HER2-Low Breast Cancer. Today, the U.S. Food and Drug Administration approved Enhertu (fam-trastuzumab-deruxtecan-nxki), an IV infusion for the treatment of patients with unresectable (unable to be removed) or metastatic (spread to other parts of the body) HER2-low breast cancer. What is dosage form and strength of Enhertu ? Please also tell how it can be taken . Enhertu is supplied as an injection of 100 mg lyophilized powder in a single-dose vial , normally given as an IV (intravenous) infusion once enery 3 weeks , still we would suggest to ask a authorised doctor before taking a specific dose of Enhertu , and please don’t take this medicine without the advice of an authenticated doctor . Is there hair loss with the patients of Enhertu ? Yes , hair loss is a common side effect faced by the patients of Enhertu own country ?

2. Yes Indian pharma network Named Patient program help’s patient to procure the medicines which are not available or approved in one’s own country . Indian pharma network provides access to Enhertu(Fam-trastuzumab deruxtecan-nxki) Manufactured by: Daiichi Sankyo, Inc., and Marketed by AstraZeneca Pharmaceuticals LP, Wilmington . Source - https://helpforheallth.blogspot.com/2022/09/enhertu-anti-cancer-drug.html